SOURCE: MBF Financial

MBF Financial

June 04, 2009 07:42 ET Posts Free Analyst Report on NIHD, PPDI, PRGN and ZION

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Maybach

Free Analyst Review

LONDON--(Marketwire - June 4, 2009) - is one of the fastest growing independent and unbiased research firms in Europe. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking free research on NII Holdings Inc. (NASDAQ: NIHD), Pharmaceutical Product Development Inc. (NASDAQ: PPDI), Paragon Shipping Inc. (NASDAQ: PRGN) and Zions Bancorp. (NASDAQ: ZION) should take this opportunity to sign up for free subscription by clicking the link below.

Many research reports sell for $15 to well over $1,000 as a member to MBF Financial you can gain access to the top reports for free by simply clicking the link above. Our reports include buy and sell recommendations, short term target prices, as well as research in the following areas:

--  Margin changes, specifically operating, gross, and then net
--  Pace and quality of top line growth
--  Ability to generate cash
--  Pace and quality of the bottom line growth
--  Market share gains
--  Innovation/pipeline
--  Corporate governance
--  Management's ability to operate in unfavorable environments
--  Ability of management to control acquisitive growth and achieve
    accretive results

Sign up to gain analyst insight for the above companies by following this link:

Analyst reviews will be posted in the member's area of under "Analyst Reviews."

Whether trading on the NYSE, Nasdaq, Amex, TSX or TSX-V, our experienced research team will investigate prime investment opportunities on behalf of the subscribers to offer a comprehensive look at what is happening and why. Sign up today at for a free subscription. Reports vary by sector and markets and look at various aspects of each company to provide an unbiased view and provide pertinent information so investors can make informed decisions regarding their portfolios.

Maybach Financial (Maybach) is not a registered broker dealer or a registered investment advisor. However, we do use information from licensed analysts. No information accessed through the Maybach Web site or this release constitutes a recommendation to buy, sell or hold any security in any jurisdiction. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Analyst reviews may or may not contain all the information listed above as each opinion and review varies with each company reviewed.

Please view the full disclaimer: